28.06.2012 • NewsPlastics & PolymersArkemainvestments

Arkema Invests over €70 Million in Fluoropolymers in France

Arkema announces a major project for the development of its Kynar PVDF business in Europe. Over €70 million are to be invested into the Pierre-Bénite site in France, in particular to increase Kynar PVDF production capacity by 50%, and so support customers in high-growth applications.

This capital expenditure plan will help increase by 50% fluoropolymer production capacity in Pierre-Bénite by 2014. It also entails major technological advances such as the implementation of an innovative high purity process, a new effluent treatment plant, and a contribution to investments for the implementation of the site's Technological Risk Prevention Plan.

 

 

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read